151 related articles for article (PubMed ID: 11998899)
1. Autoantibody responses in Chinese hepatocellular carcinoma.
Zhang JY; Wang X; Peng XX; Chan EK
J Clin Immunol; 2002 Mar; 22(2):98-105. PubMed ID: 11998899
[TBL] [Abstract][Full Text] [Related]
2. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
3. Diversity of antinuclear antibody responses in hepatocellular carcinoma.
Covini G; von Mühlen CA; Pacchetti S; Colombo M; Chan EK; Tan EM
J Hepatol; 1997 Jun; 26(6):1255-65. PubMed ID: 9210612
[TBL] [Abstract][Full Text] [Related]
4. Humoral autoimmune response to nucleophosmin in the immunodiagnosis of hepatocellular carcinoma.
Liu M; Varela-Ramirez A; Li J; Dai L; Aguilera RJ; Zhang JY
Oncol Rep; 2015 May; 33(5):2245-52. PubMed ID: 25779011
[TBL] [Abstract][Full Text] [Related]
5. Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma.
Imai H; Nakano Y; Kiyosawa K; Tan EM
Cancer; 1993 Jan; 71(1):26-35. PubMed ID: 8380118
[TBL] [Abstract][Full Text] [Related]
6. Immunocytochemical characterization of human NOR-90 (upstream binding factor) and associated antigens reactive with autoimmune sera. Two MR forms of NOR-90/hUBF autoantigens.
Imai H; Fritzler MJ; Neri R; Bombardieri S; Tan EM; Chan EK
Mol Biol Rep; 1994 Mar; 19(2):115-24. PubMed ID: 8072492
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to survivin in patients with chronic hepatitis and hepatocellular carcinoma.
Yagihashi A; Asanuma K; Kobayashi D; Tsuji N; Torigoe T; Sato N; Watanabe N
Autoimmunity; 2005 Sep; 38(6):445-8. PubMed ID: 16278150
[TBL] [Abstract][Full Text] [Related]
8. Nucleolar antigens and autoantibodies in hepatocellular carcinoma and other malignancies.
Imai H; Ochs RL; Kiyosawa K; Furuta S; Nakamura RM; Tan EM
Am J Pathol; 1992 Apr; 140(4):859-70. PubMed ID: 1314027
[TBL] [Abstract][Full Text] [Related]
9. A distinct repertoire of autoantibodies in hepatocellular carcinoma identified by proteomic analysis.
Le Naour F; Brichory F; Misek DE; Bréchot C; Hanash SM; Beretta L
Mol Cell Proteomics; 2002 Mar; 1(3):197-203. PubMed ID: 12096119
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies to IGF-II mRNA binding protein p62 and overexpression of p62 in human hepatocellular carcinoma.
Zhang J; Chan EK
Autoimmun Rev; 2002 May; 1(3):146-53. PubMed ID: 12849008
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of Ra1A and its tissue-specific expression in hepatocellular carcinoma.
Wang K; Chen Y; Liu S; Qiu S; Gao S; Huang X; Zhang J; Peng X; Qiani W; Zhang JY
Int J Immunopathol Pharmacol; 2009; 22(3):735-43. PubMed ID: 19822090
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to Golgi proteins in hepatocellular carcinoma: case report and literature review.
Mozo L; Simó A; Suárez A; Rodrigo L; Gutiérrez C
Eur J Gastroenterol Hepatol; 2002 Jul; 14(7):771-4. PubMed ID: 12169987
[TBL] [Abstract][Full Text] [Related]
13. A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma.
Zhang JY; Chan EK; Peng XX; Tan EM
J Exp Med; 1999 Apr; 189(7):1101-10. PubMed ID: 10190901
[TBL] [Abstract][Full Text] [Related]
14. [Prevalence of anti-HCV in sera of patients with hepatocellular carcinoma].
Yu ZY
Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):44-6. PubMed ID: 7687532
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies against glucose-regulated protein 78 as serological diagnostic biomarkers in hepatocellular carcinoma.
Shao Q; Ren P; Li Y; Peng B; Dai L; Lei N; Yao W; Zhao G; Li L; Zhang J
Int J Oncol; 2012 Sep; 41(3):1061-7. PubMed ID: 22692946
[TBL] [Abstract][Full Text] [Related]
16. De-novo humoral immune responses to cancer-associated autoantigens during transition from chronic liver disease to hepatocellular carcinoma.
Zhang JY; Zhu W; Imai H; Kiyosawa K; Chan EK; Tan EM
Clin Exp Immunol; 2001 Jul; 125(1):3-9. PubMed ID: 11472419
[TBL] [Abstract][Full Text] [Related]
17. Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma.
Zhang JY; Megliorino R; Peng XX; Tan EM; Chen Y; Chan EK
J Hepatol; 2007 Jan; 46(1):107-14. PubMed ID: 17067715
[TBL] [Abstract][Full Text] [Related]
18. Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies.
Wang Y; Han KJ; Pang XW; Vaughan HA; Qu W; Dong XY; Peng JR; Zhao HT; Rui JA; Leng XS; Cebon J; Burgess AW; Chen WF
J Immunol; 2002 Jul; 169(2):1102-9. PubMed ID: 12097419
[TBL] [Abstract][Full Text] [Related]
19. Identification of hepatocellular-carcinoma-associated antigens and autoantibodies by serological proteome analysis combined with protein microarray.
Li L; Chen SH; Yu CH; Li YM; Wang SQ
J Proteome Res; 2008 Feb; 7(2):611-20. PubMed ID: 18161940
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies to the nucleolar organizer antigen NOR-90 in children with systemic rheumatic diseases.
Fritzler MJ; von Muhlen CA; Toffoli SM; Staub HL; Laxer RM
J Rheumatol; 1995 Mar; 22(3):521-4. PubMed ID: 7783073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
